Nucleix
Business Services · Israel · 51-200 Employees
View Company Info for Free
Overview
Headquarters
20 Hasatat St, Modi'in, 7171101, IsraelPhone Number
(858) 283-3398Website
www.nucleix.comRevenue
<$5 MillionIndustry
About Nucleix
Nucleix is a liquid biopsy company revolutionizing cancer treatment with earlier disease detection at a time when intervention can bring the greatest impact for patients. Leveraging NGS and PCR-based epigenetics, the Company's pioneering testing approach uses methylation-based identification for early-stage and recurring cancer detection. The Company's non-invasive EpiCheck® platform delivers highly accurate and sensitive results, all while providing a seamless testing option for patients and the healthcare system. The Company is building an EpiCheck franchise, beginning with the Bladder EpiCheck® testing kit, marketed in Europe for bladder cancer recurrence. The Company is advancing a Lung EpiCheck test toward commercialization for high-risk individuals, while advancing additional tests for high-risk diseases.Explore more
Nucleix Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Nucleix Tech Stack
A closer look at the technologies used by Nucleix
Top Business Services Companies
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Nucleix
Sign Up For FreeTo access detailed company insights
Nucleix is a liquid biopsy company revolutionizing cancer treatment with earlier disease detection at a time when intervention can bring the greatest impact for patients. Leveraging NGS and PCR-based epigenetics, the Company's pioneering testing approach uses methylation-based identification for early-stage and recurring cancer detection. The Compa... Read More
